Prosecution Insights
Last updated: April 19, 2026

Zetagen Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19280749 COMPOSITIONS USING IRON EXCIPIENTS AND THEIR USES INCLUDING FOR THE TREATMENT OF CANCER PERREIRA, MELISSA JEAN 1618 Final Rejection Jul 25, 2025
18463056 METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS HAGOPIAN, CASEY SHEA 1617 Non-Final OA Sep 07, 2023

Managing Zetagen Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month